Effect of Smartphone Addiction on Myoelectrical Activity of Sternocleidomastoid Muscle in Adult

Sponsor
Cairo University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06112496
Collaborator
(none)
44
3.3

Study Details

Study Description

Brief Summary

This study will be conducted to identify the effect of smartphone addiction myoelectrical activity on sternocleidomastoid in adults by measuring The amplitude of EMG signals of the sternocleidomastoid muscle in adults and Root mean square of EMG signals of the sternocleidomastoid muscle in adults

Condition or Disease Intervention/Treatment Phase
  • Device: EMG

Study Design

Study Type:
Observational
Anticipated Enrollment :
44 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
Effect of Smartphone Addiction on the Myoelectrical Activity of the Sternocleidomastoid Muscle in Adult
Anticipated Study Start Date :
Oct 23, 2023
Anticipated Primary Completion Date :
Jan 1, 2024
Anticipated Study Completion Date :
Feb 1, 2024

Arms and Interventions

Arm Intervention/Treatment
smart phone addict

Device: EMG
Neuro-EMG-Micro, Neurosoft, Ivanovo, Russia, will be used for the assessment of muscle activity for muscles.

smart phone non addict

Device: EMG
Neuro-EMG-Micro, Neurosoft, Ivanovo, Russia, will be used for the assessment of muscle activity for muscles.

Outcome Measures

Primary Outcome Measures

  1. Changes in surface electromyographic (EMG) amplitude of sternocleidomastoid muscle [day 1]

    change in amplitude measured by EMG device

  2. change in RMS [day 1]

    change in root mean square measured by EMG device

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 30 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Subject's age range from 18-30 years old

  • All participants use the same smartphone with a touch screen of 6,7 inches.

Exclusion Criteria:
  • Neck pain ( spondylosis, spondylolysis)

  • Systemic diseases.

  • Spinal deviation

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Cairo University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Huda Adel Mohammed Hassan, principal investigator, Cairo University
ClinicalTrials.gov Identifier:
NCT06112496
Other Study ID Numbers:
  • P.T.REC/012/004614
First Posted:
Nov 1, 2023
Last Update Posted:
Nov 1, 2023
Last Verified:
Oct 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 1, 2023